Location of Retroperitoneal Lymph Node Metastases in Upper Tract Urothelial Carcinoma: Results from a Prospective Lymph Node Mapping Study

被引:2
作者
Bobjer, Johannes [1 ,2 ,9 ]
Gerdtsson, Axel [1 ,2 ]
Abrahamsson, Johan [1 ,2 ]
Baseckas, Gediminas [2 ]
Bergkvist, Mats [3 ]
Blackberg, Mats [4 ]
Brandstedt, Johan [1 ,2 ]
Jancke, Georg [5 ]
Hagberg, Oskar [1 ,2 ]
Kollberg, Petter [6 ]
Lundstrom, Karl-Johan [6 ,7 ]
Lofgren, Annica [1 ,2 ]
Nyberg, Martin [1 ,2 ]
Martensson, Liselotte Rian [8 ]
Saemundsson, Ymir [1 ,2 ]
Stahl, Elin [1 ,2 ]
Sorenby, Anne [1 ,2 ]
Liedberg, Fredrik [1 ,2 ]
机构
[1] Lund Univ, Dept Translat Med, Malmo, Sweden
[2] Skane Univ Hosp, Dept Urol, Malmo, Sweden
[3] Karolinska Univ Hosp, Pelv Canc Med Unit, Stockholm, Sweden
[4] Helsingborg Cty Hosp, Dept Urol, Helsingborg, Sweden
[5] Linkoping Univ, Dept Clin & Expt Med, Div Urol, Linkoping, Sweden
[6] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden
[7] Ostersund Cty Hosp, Dept Urol, Ostersund, Sweden
[8] Trondheim Reg & Univ Hosp, Dept Urol, Trondheim, Norway
[9] Skane Univ Hosp, Dept Urol, Jan Waldenstroms Gata 7, S-20502 Malmo, Sweden
来源
EUROPEAN UROLOGY OPEN SCIENCE | 2023年 / 57卷
基金
瑞典研究理事会;
关键词
Urinary tract cancer; Lymph node dissection; Lymph node metastases; TEMPLATE-BASED LYMPHADENECTOMY; TRANSITIONAL-CELL CARCINOMA; BLADDER-CANCER; RENAL PELVIS; DISSECTION; NEPHROURETERECTOMY; FEASIBILITY; RECURRENCE;
D O I
10.1016/j.euros.2023.09.010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: There is limited information on the distribution of retroperitoneal lymph node metastases (LNMs) in upper tract urothelial carcinoma (UTUC).Objective: To investigate the location of LNMs in UTUC of the renal pelvis or proximal ureter and short-term complications after radical nephroureterectomy (RNU) with lymph node dissection (LND). Design, setting, and participants: This was a prospective Nordic multicenter study (four university hospitals, two county hospitals). Patients with clinically suspected locally advanced UTUC (stage >T1) and/or clinical lymph node-positive (cN+) dis-ease were invited to participate. Participants underwent RNU and fractionated retroperitoneal LND using predefined side-specific templates. Outcome measurements and statistical analysis: The location of LNMs in the LND specimen and retroperitoneal lymph node recurrences during follow-up was recorded. Postoperative complications within 90 d of surgery were ascertained from patient charts. Descriptive statistics were used.Results and limitations: LNMs were present in the LND specimen in 23/100 patients, and nine of 100 patients experienced a retroperitoneal recurrence. Distribution per side revealed LNMs in the LND specimen in 11/38 (29%) patients with right-sided tumors, for whom the anatomically larger, right-sided template was used, in comparison to 12/62 (19%) patients with left-sided tumors, for whom a more limited template was used. High-grade complications (Clavien grade >= 3) within 90 d of surgery were registered for 13/100 patients. The study is limited in size and not powered to assess survival estimates.Conclusions: The suggested templates that we prospectively applied for right-sided and left-sided LND in patients with advanced UTUC included the majority of LNMs. High-grade complications directly related to the LND part of the surgery were limited.Patient summary: This study describes the location of lymph node metastases in patients with cancer in the upper urinary tract who underwent surgery to remove the affected kidney and ureter. The results show that most metastases occur within the template maps for lymph node surgery that we investigated, and that this surgery can be performed with few severe complications.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 27 条
  • [1] Complete metabolic response with [18F]fluorodeoxyglucose-positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinically lymph node positive bladder cancer
    Abrahamsson, Johan
    Kollberg, Petter
    Almquist, Helen
    Blackberg, Mats
    Brandstedt, Johan
    Lyttkens, Kerstin
    Simoulis, Athanasios
    Sjodahl, Gottfrid
    Sorenby, Anne
    Tragardh, Elin
    Liedberg, Fredrik
    [J]. BJU INTERNATIONAL, 2022, 129 (02) : 174 - 181
  • [2] Preoperative predictors of pathological tumour stage and prognosis may be used when selecting candidates for intensified treatment in upper tract urothelial carcinoma
    Almas, Bjarte
    overby, Stein
    Halvorsen, Ole J.
    Reisaeter, Lars A. R.
    Carlsen, Birgitte
    Beisland, Christian
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY, 2021, 55 (02) : 100 - 107
  • [3] Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
    Bajorin, D. F.
    Witjes, J. A.
    Gschwend, J. E.
    Schenker, M.
    Valderrama, B. P.
    Tomita, Y.
    Bamias, A.
    Lebret, T.
    Shariat, S. F.
    Park, S. H.
    Ye, D.
    Agerbaek, M.
    Enting, D.
    McDermott, R.
    Gajate, P.
    Peer, A.
    Milowsky, M., I
    Nosov, A.
    Antonio Jr, J. N.
    Tupikowski, K.
    Toms, L.
    Fischer, B. S.
    Qureshi, A.
    Collette, S.
    Unsal-Kacmaz, K.
    Broughton, E.
    Zardavas, D.
    Koon, H. B.
    Galsky, M. D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (22) : 2102 - 2114
  • [4] Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial
    Birtle, Alison
    Johnson, Mark
    Chester, John
    Jones, Robert
    Dolling, David
    Bryan, Richard T.
    Harris, Christopher
    Winterbottom, Andrew
    Blacker, Anthony
    Catto, James W. F.
    Chakraborti, Prabir
    Donovan, Jenny L.
    Elliott, Paul Anthony
    French, Ann
    Jagdev, Satinder
    Jenkins, Benjamin
    Keeley, Francis Xavier, Jr.
    Kockelbergh, Roger
    Powles, Thomas
    Wagstaff, John
    Wilson, Caroline
    Todd, Rachel
    Lewis, Rebecca
    Hall, Emma
    [J]. LANCET, 2020, 395 (10232) : 1268 - 1277
  • [5] Brierley JD., 2017, TNM CLASSIFICATION M
  • [6] Optimizing the Sequence of Chemotherapy for Upper Tract Urothelial Carcinoma with Clinically Positive Regional Lymph Nodes
    Chakiryan, Nicholas
    Martinez, Ann
    Gao, Lina
    Liu, Jen-Jane
    Amling, Christopher
    Garzotto, Mark
    Kopp, Ryan P.
    [J]. JOURNAL OF UROLOGY, 2019, 202 (01) : 76 - 81
  • [7] Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
    Gerdtsson, Axel
    Thor, Anna
    Bergdahl, Anna Grenabo
    Almas, Bjarte
    Hakansson, Ulf
    Tornblom, Magnus
    Negaard, Helene F. S.
    Glimelius, Ingrid
    Halvorsen, Dag
    Karlsdottir, Asa
    Haugnes, Hege Sagstuen
    Andreassen, Kristine Engen
    Larsen, Signe Melsen
    Holmberg, Goran
    Wahlqvist, Rolf
    Tandstad, Torgrim
    Cohn-Cedermark, Gabriella
    Stahl, Olof
    Kjellman, Anders
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (02): : 235 - 243
  • [8] The role of lymphadenectomy at the time of radical nephroureterectomy for upper tract urothelial carcinoma
    Goltzman, Michael E.
    Gogoj, Augustyna
    Ristau, Benjamin T.
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (04) : 1860 - 1867
  • [9] Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients
    Hall, MC
    Womack, S
    Sagalowsky, AI
    Carmody, T
    Erickstad, MD
    Roehrborn, CG
    [J]. UROLOGY, 1998, 52 (04) : 594 - 601
  • [10] Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy
    Herr, HW
    Donat, SM
    [J]. JOURNAL OF UROLOGY, 2001, 165 (01) : 62 - 64